𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gemtuzumab ozogamicin as maintenance therapy after autologous stem cell transplantation in elderly patients with acute myeloid leukaemia

✍ Scribed by Nicola Cascavilla; Giovanni D’Arena; Michele Mario Greco; Lorella Melillo; Emanuela Merla; Angelo Michele Carella

Book ID
108675859
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
55 KB
Volume
142
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Autologous stem cell transplantation for
Autologous stem cell transplantation for elderly patients with acute myeloid leukaemia conditioned with continuous infusion idarubicin and busulphan
✍ Felicetto Ferrara; Salvatore Palmieri; Mariangela Pedata; Assunta Viola; Tiziana 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## Abstract Different studies have suggested the potential utility of autologous stem cell transplantation (ASCT) in acute myeloid leukaemia (AML) of the elderly with encouraging results in selected patients. However, while the introduction of peripheral blood stem cells (PBSC) has consistently red

Continuous infusion idarubicin and intra
Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia
✍ Felicetto Ferrara; Giuseppina Mele; Salvatore Palmieri; Mariangela Pedata; Carol 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract The current study aimed to evaluate the efficacy and toxicity of a combination of intravenous (iv) busulfan (Bu) and continuous infusion Idarubicin (IDA) as a conditioning regimen to autologous haematopoietic stem cell transplantation (ASCT) in patients with acute myeloid leukaemia (AML